BVL3572S
BVL3572S, a hydroxamic acid derivative, exhibits potent bactericidal activity against Mycobacterium tuberculosis (Mtb) with a MIC90 of 1.7 µM. BVL3572S inhibits pyridoxal phosphate (PLP) -dependent aminotransferases HisC and AlaA to kill Mtb. BVL3572S can be used for tuberculosis (TB) research[1].
Product Specifications
CAS Number
[1258544-63-6]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Inflammation/Immunology
Smiles
ON1C2=CC(Br)=CC=C2C[C@H](N)C1=O
Molecular Formula
C9H9BrN2O2
Molecular Weight
257.08
References & Citations
[1]Zainab Edoo, et al. Exploiting Vitamin B6 Dependency: BVL3572S Inhibits HisC and AlaA to Kill Mycobacterium. bioRxiv. October 27, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
